Stroke-associated sarcopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meeting the diagnostic criteria for cerebral infarction and cerebral hemorrhage as stipulated in the "Key Points for Diagnosis of Major Cerebrovascular Diseases in China 2019", and confirmed by CT or MRI examination; 2. Meeting the diagnostic criteria for low muscle mass, low muscle strength and physical function impairment as specified in the "Diagnosis and Treatment Guidelines for Sarcopenia in China 2024 Edition"; 3. Brunnstrom stage of upper limb <= 3; 4. Age ranging from 45 to 89 years old; 5. Stroke duration within 1 to 4 weeks; 6. Patients or their families have signed the informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. Combined with severe functional impairments of important organs such as the heart, liver and kidneys. 2. Has severe cognitive impairment and is unable to cooperate with the treatment. 3. Suffers from other diseases that may cause muscle loss, such as malignant tumors and severe endocrine disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer;Muscle thickness;The strength of the healthy side;Muscle mass; | — |
Secondary
| Measure | Time frame |
|---|---|
| prealbumin;neural functional recovery;activities of daily living; | — |
Countries
China
Contacts
Affiliated Hospital of North China University of Technology